195 related articles for article (PubMed ID: 25113655)
21. Hereditary angioedema education in otolaryngology residencies: survey of program directors.
Patel VA; Siddique L; Stahl L; Carr MM
Int Forum Allergy Rhinol; 2018 Jul; 8(7):850-856. PubMed ID: 29543388
[TBL] [Abstract][Full Text] [Related]
22. Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study.
Steiner UC; Weber-Chrysochoou C; Helbling A; Scherer K; Grendelmeier PS; Wuillemin WA
Orphanet J Rare Dis; 2016 Apr; 11():43. PubMed ID: 27101900
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
[TBL] [Abstract][Full Text] [Related]
24. Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
Wahn V; Aberer W; Aygören-Pürsün E; Bork K; Eberl W; Faßhauer M; Krüger R; Magerl M; Martinez-Saguer I; Späth P; Staubach-Renz P; Weber-Chrysochoou C
Pediatr Allergy Immunol; 2020 Nov; 31(8):974-989. PubMed ID: 32524650
[TBL] [Abstract][Full Text] [Related]
25. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
26. HEREDITARY ANGIOEDEMA DUE TO C1-INHIBITOR DEFICIENCY IN PEDIATRIC PATIENTS IN CROATIA - FIRST NATIONAL STUDY, DIAGNOSTIC AND PROPHYLACTIC CHALLENGES.
Karadža-Lapić L; Barešić M; Vrsalović R; Ivković-Jureković I; Sršen S; Prkačin I; Rijavec M; Cikojević D
Acta Clin Croat; 2019 Mar; 58(1):139-146. PubMed ID: 31363336
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
29. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
30. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
Tallroth GA
Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
[TBL] [Abstract][Full Text] [Related]
31. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and treatment of hereditary angioedema with normal C1-inhibitor level].
Emelyanov AV; Leshenkova EV; Kameneva GA
Ter Arkh; 2020 Dec; 92(12):86-90. PubMed ID: 33720579
[TBL] [Abstract][Full Text] [Related]
33. Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry.
Psarros F; Koutsostathis N; Farmaki E; Speletas MG; Germenis AE
Int Arch Allergy Immunol; 2014; 164(4):326-32. PubMed ID: 25277223
[TBL] [Abstract][Full Text] [Related]
34. C1 inhibitor deficiency: 2014 United Kingdom consensus document.
Longhurst HJ; Tarzi MD; Ashworth F; Bethune C; Cale C; Dempster J; Gompels M; Jolles S; Seneviratne S; Symons C; Price A; Edgar D
Clin Exp Immunol; 2015 Jun; 180(3):475-83. PubMed ID: 25605519
[TBL] [Abstract][Full Text] [Related]
35. C1-esterase inhibitor (Cinryze
Gupta R; Balduzzi J; Davis-Lorton M
Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
[TBL] [Abstract][Full Text] [Related]
36. Plasma-derived C1-INH for managing hereditary angioedema in pediatric patients: A systematic review.
Craig TJ; Schneider LC; MacGinnitie AJ
Pediatr Allergy Immunol; 2015 Sep; 26(6):537-44. PubMed ID: 26111105
[TBL] [Abstract][Full Text] [Related]
37. Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study.
Savarese L; Bova M; De Falco R; Guarino MD; De Luca Picione R; Petraroli A; Senter R; Traverso C; Zabotto M; Zanichelli A; Zito E; Alessio M; Cancian M; Cicardi M; Franzese A; Perricone R; Marone G; Valerio P; Freda MF
Orphanet J Rare Dis; 2018 Jul; 13(1):115. PubMed ID: 30005674
[TBL] [Abstract][Full Text] [Related]
38. Management and prevention of hereditary angioedema attacks.
Lumry WR
Am J Manag Care; 2013 Jun; 19(7 Suppl):s111-8. PubMed ID: 23844783
[TBL] [Abstract][Full Text] [Related]
39. Current medical management of hereditary angioedema: results from a large survey of US physicians.
Riedl M; Gower RG; Chrvala CA
Ann Allergy Asthma Immunol; 2011 Apr; 106(4):316-322.e4. PubMed ID: 21457880
[TBL] [Abstract][Full Text] [Related]
40. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States.
Riedl MA; Banerji A; Manning ME; Burrell E; Joshi N; Patel D; Machnig T; Tai MH; Watson DJ
Orphanet J Rare Dis; 2018 Oct; 13(1):180. PubMed ID: 30314518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
